首页 > 市场调查报告书 > 製药

医药品法规环境

市场调查报告书

商品编码

1547885

全球药物警戒与药物安全软体市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Pharmacovigilance and Drug Safety Software Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 171 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球药物警戒和药物安全软体市场需求预计将从 2023 年的 2.0157 亿美元达到 2032 年的近 3.7939 亿美元，2024-2032 年研究期间复合年增长率为 7.28%。

药物警戒和药物安全软体是一种降低产品安全风险、实现合规性并提高药物警戒流程效率的应用程式。它可以确定戒断的原因，并有助于抑制未来不必要的事件。软体报告并管理安全和监管，持续追踪向政府和客户提供的状态报告，允许存取记录和医学进步专业知识。该软体得到了监管机构、製药公司和医疗专业人员的批准。

市场动态

自动化和数位化是每个领域的日益增长的趋势，包括临床研究。对新疗法和药物的不断增长的研究正在促进市场的成长。危及生命的传染性疾病对死亡率和发病率有巨大影响，并给受影响国家带来严重的经济困难。目前，现有药物不足以治疗大多数此类疾病，迫切需要新的治疗方法。从研究开始到结束，药物警戒软体在临床研究中发挥着至关重要的作用。该软体透过将资讯整合到熟悉的位置来帮助减轻管理负担和工作量，透过促进所有研究之间的合作来支持试验轮次。该软体的结合极大地提高了研究或研究资料的维护、规划、执行、管理和报告的速度和效率。药物警戒和药物安全软体是临床研究领域收集试验资料以追踪研究表现、时间表、监测等的重要工具。由于具有巨大的优势，预计将有越来越多的临床研究使用该软体来获取收益，最终将导致市场的健康成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球药物警戒和药物安全软体市场的每个细分市场进行包容性评估。药物警戒和药物安全软体产业的成长和趋势为本研究提供了整体方法。

市场区隔

药物警戒和药物安全软体市场报告的这一部分提供了国家和地区层面细分市场的详细资料，从而帮助战略家确定相应产品或服务的目标人群以及即将到来的机会。

按功能分类

案例资料收集和管理
不良事件报告和分析
讯号侦测及其他安全风险评估

按交付方式

内部部署
一经请求

按最终用途

医疗保健公司（製药和生物技术公司）
外包时的 CRO/BPO 或光伏服务供应商。
其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲药物警戒和药物安全软体市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。药物警戒和药物安全软体市场的主要参与者包括 IQVIA、埃森哲、Cognizant、Laboratory Corporation Of America Holdings、IBM、ArisGlobal、ICON Plc.、Capgemini、Oracle、Parexel International Corporation。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：药物警戒与药品安全软体公司的竞争格局

药物警戒和药物安全软体市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

顶级公司市占率分析
市场集中度
IQVIA

公司概况
公司收入
产品
最新动态

Accenture

公司概况
公司收入
产品
最新动态

Cognizant

公司概况
公司收入
产品
最新动态

Laboratory Corporation Of America Holdings

公司概况
公司收入
产品
最新动态

公司概况
公司收入
产品
最新动态

ArisGlobal

公司概况
公司收入
产品
最新动态

ICON Plc.

公司概况
公司收入
产品
最新动态

Capgemini

公司概况
公司收入
产品
最新动态

Oracle

公司概况
公司收入
产品
最新动态

Parexel International Corporation

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11212598

The global demand for Pharmacovigilance and Drug Safety Software Market is presumed to reach the market size of nearly USD 379.39 Million by 2032 from USD 201.57 Million in 2023 with a CAGR of 7.28% under the study period 2024-2032.

Pharmacovigilance and drug safety software is an application that reduces product safety risk, achieves compliance, and improves the efficiency of pharmacovigilance processes. It identifies the cause of withdrawal and helps to inhibit unnecessary future events. Software reports and manages safety and regulation, consistently track status reports to governments and clients, enable access to records, and medicine advancement expertise. The software is approved by regulating agencies, pharmaceutical companies, and medical professionals.

MARKET DYNAMICS

Automation and digitalization is an increasing trend in every sector, including clinical research. Growing research on new therapies and drugs is augmenting the growth of the market. Infectious life-threatening diseases have a massive effect in terms of mortality and morbidity and oblige substantial economic trouble on affected countries. Currently, available drugs are insufficient for the majority of these diseases, and there is an urgent need for new treatments. From a research start to close out, pharmacovigilance software plays a crucial role in clinical research. This software help reduce the administrative burdens and workloads by consolidating information in a familiar location, supports the trial round by facilitating the cooperation between all the researches. Incorporation of this software dramatically enhances the speed and efficiency in maintaining, planning, performing, managing, and reporting of the research or study data. Pharmacovigilance and Drug Safety Softwares are great tools in the clinical research domain to collect trial data to track study performance, schedule, monitor, and many more. Due to a massive bundle of advantages, it is predicted that more and more clinical research will use this software to grab the benefits that will eventually result in the healthy growth of the market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Pharmacovigilance and Drug Safety Software. The growth and trends of Pharmacovigilance and Drug Safety Software industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Pharmacovigilance and Drug Safety Software market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Functionality

Case Data Collection and Management
Adverse Event Reporting and Analysis
Signal Detection and Other Safety Risk Assessment

By Delivery Mode

On Premise
On Demand

By End Use

Healthcare Companies (Pharmaceuticals & Biotechnology Companies)
CROs/BPOs or PV Service Providers When Outsourced.
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Pharmacovigilance and Drug Safety Software market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Pharmacovigilance and Drug Safety Software market include IQVIA, Accenture, Cognizant, Laboratory Corporation Of America Holdings, IBM, ArisGlobal, ICON Plc., Capgemini, Oracle, Parexel International Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Functionality
- 3.7.2 Market Attractiveness Analysis By Delivery Mode
- 3.7.3 Market Attractiveness Analysis By End Use
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ANALYSIS BY FUNCTIONALITY

5.1. Overview By Functionality
5.2. Historical and Forecast Data
5.3. Analysis By Functionality
5.4. Case Data Collection and Management Historic and Forecast Sales By Regions
5.5. Adverse Event Reporting and Analysis Historic and Forecast Sales By Regions
5.6. Signal Detection and Other Safety Risk Assessment Historic and Forecast Sales By Regions

6. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ANALYSIS BY DELIVERY MODE

6.1. Overview By Delivery Mode
6.2. Historical and Forecast Data
6.3. Analysis By Delivery Mode
6.4. On Premise Historic and Forecast Sales By Regions
6.5. On Demand Historic and Forecast Sales By Regions

7. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ANALYSIS BY END USE

7.1. Overview By End Use
7.2. Historical and Forecast Data
7.3. Analysis By End Use
7.4. Healthcare Companies (Pharmaceuticals & Biotechnology Companies) Historic and Forecast Sales By Regions
7.5. CROs/BPOs or PV Service Providers When Outsourced. Historic and Forecast Sales By Regions
7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE COMPANIES

9.1. Pharmacovigilance and Drug Safety Software Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF PHARMACOVIGILANCE AND DRUG SAFETY SOFTWARE INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. IQVIA
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Accenture
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Cognizant
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Laboratory Corporation Of America Holdings
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. IBM
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. ArisGlobal
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. ICON Plc.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Capgemini
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Oracle
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Parexel International Corporation
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

简介目录图表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Functionality (USD MN)
Case Data Collection and Management Market Sales By Geography (USD MN)
Adverse Event Reporting and Analysis Market Sales By Geography (USD MN)
Signal Detection and Other Safety Risk Assessment Market Sales By Geography (USD MN)
Analysis By Delivery Mode (USD MN)
On Premise Market Sales By Geography (USD MN)
On Demand Market Sales By Geography (USD MN)
Analysis By End Use (USD MN)
Healthcare Companies (Pharmaceuticals & Biotechnology Companies) Market Sales By Geography (USD MN)
CROs/BPOs or PV Service Providers When Outsourced. Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Pharmacovigilance and Drug Safety Software Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Pharmacovigilance and Drug Safety Software Report
Market Research Process
Market Research Methodology
Global Pharmacovigilance and Drug Safety Software Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Functionality
Market Attractiveness Analysis By Delivery Mode
Market Attractiveness Analysis By End Use
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Functionality (USD MN)
Case Data Collection and Management Market Sales By Geography (USD MN)
Adverse Event Reporting and Analysis Market Sales By Geography (USD MN)
Signal Detection and Other Safety Risk Assessment Market Sales By Geography (USD MN)
Global Market Analysis By Delivery Mode (USD MN)
On Premise Market Sales By Geography (USD MN)
On Demand Market Sales By Geography (USD MN)
Global Market Analysis By End Use (USD MN)
Healthcare Companies (Pharmaceuticals & Biotechnology Companies) Market Sales By Geography (USD MN)
CROs/BPOs or PV Service Providers When Outsourced. Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis